Amici Capital’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-35,390
Closed -$2.43M 53
2016
Q4
$2.43M Sell
35,390
-34,610
-49% -$2.48M 0.95% 31
2016
Q3
$4.94M Sell
70,000
-207,791
-75% -$15.5M 1.29% 26
2016
Q2
$21.1M Sell
277,791
-477,770
-63% -$35.1M 3.96% 4
2016
Q1
$51.9M Buy
755,561
+125,500
+20% +$9.02M 6.15% 2
2015
Q4
$55.1M Sell
630,061
-16,500
-3% -$1.41M 3.86% 4
2015
Q3
$52.3M Buy
646,561
+25,097
+4% +$2.19M 2.5% 8
2015
Q2
$55.3M Buy
621,464
+5,900
+1% +$515K 2.01% 16
2015
Q1
$53.4M Sell
615,564
-9,600
-2% -$805K 1.92% 17
2014
Q4
$52.9M Sell
625,164
-381,636
-38% -$29.8M 2.38% 11
2014
Q3
$71.1M Buy
1,006,800
+30,000
+3% +$2.14M 2.36% 10
2014
Q2
$67.7M Sell
976,800
-37,985
-4% -$2.67M 2.14% 13
2014
Q1
$76.2M Sell
1,014,785
-577,185
-36% -$43.2M 2.5% 10
2013
Q4
$112M Sell
1,591,970
-155,000
-9% -$10.1M 3.53% 5
2013
Q3
$108M Sell
1,746,970
-102,430
-6% -$6.62M 3.9% 4
2013
Q2
$114M Buy
+1,849,400
New +$111M 4.17% 2

Other funds holding ESRX

Amici Capital's ESRX Position: Q1 2017 in Review

Amici Capital sold out of Express Scripts Holding Company (ESRX) in Q1 2017, closing a stake of 35,390 shares — an estimated $2.43M sold.

Amici Capital first reported a position in ESRX in Q2 2013 and held it in 15 quarters. The position peaked at $114M in Q2 2013. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q1 2017.

  • Amici Capital reported no remaining Express Scripts Holding Company position as of Q1 2017 after selling out during the quarter.
  • Amici Capital sold 35,390 Express Scripts Holding Company shares in Q1 2017, an estimated $2.43M.
  • Amici Capital first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 15 quarters.
  • Amici Capital's Express Scripts Holding Company position peaked at $114M in Q2 2013.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2017.

Based on Amici Capital's 13F filing for Q1 2017.